TGTX Price Prediction Next Week
Analysis and Insights
Technical Analysis:
TG Therapeutics (TGTX) has shown strong upward momentum recently, with the stock price increasing by 27.75% last week following positive sales results. The stock closed at $39.23 on March 10, 2025, with a pre-market percentage change of -1.77% and a regular market gain of +2.06%.
Valuation Analysis:
TGTX is currently trading at $39.23, with a market cap of $6.162B. The stock has a high RSI of 85.48, indicating overbought conditions, and the MACD is showing a bullish signal but with a weakening histogram.
News and Sentiment:
Recent news indicates bullish sentiment, with significant call option activity and a price target of $55 maintained by HC Wainwright. The stock has a high short interest and is approaching its earnings date on May 8, 2025.
Conclusion:
Based on the analysis, the stock is expected to trade between $38.50 and $43.00 next week. The recommendation is to BUY on dips near the lower end of this range, targeting a breakout above $43.00.
TGTX Similar Chart Price Prediction
The price of TGTX is predicted to go up 6.53%, based on the high correlation periods with AIRG. The similarity of these two price pattern on the periods is 95.06%.
TGTX
AIRG
Up: 6.53%Similarity: 95.06%
TGTX Revenue Forecast
TGTX EPS Forecast
TGTX FAQs
What is TGTX revenue forecast for next quarter？
TGTX Analyst's Forecast
Eric Joseph
JP Morgan
Buy
2024-11-25
Price Target
$30 → $43
Upside
+24.24%
JPMorgan raised the firm's price target on TG Therapeutics to $43 from $30 and keeps an Overweight rating on the shares. The firm says that with a potential SC Briumvi formulation coming into view beginning in the first half of 2025, it updated TG's model to reflect risk adjusted Briumvi forecasts within the at-home/self-administered anti-CD20 segment of relapsing multiple sclerosis. At $3.5B, the analyst's peak Briumvi SC forecast assumes market entry beginning in 2028 and ultimately garnering 35% share of the self-administered CD20 segment. JPMorgan sees an increasingly attractive setup to TG shares in the mid-term.
Tara Bancroft
TD Cowen
Strong Buy
2024-10-29
Price Target
$50
Upside
+94.48%
